Benjamin LA, Allain TJ, Mzinganjira H, Connor MD, Smith C, Lucas S, Joekes E, Kampondeni S, Chetcuti K, Turnbull I, et al. The role of human immunodeficiency virus-associated vasculopathy in the etiology of stroke. J Infect Dis. 2017;216:545 553. doi: 10.1093/infdis/jix340 723. Goldstein DA, Timpone J, Cupps TR. HIV-associated intracranial an- eurysmal vasculopathy in adults. J Rheumatol. 2010;37:226 233. doi: 724. Saraya T, Shimura C, Wada H, Aoshima M, Goto H. Evidence for vascular spread of varicella zoster-associated vasculopathy. Ann Intern Med. 2006; 725. WHO Secretariat. Chagas disease: control and elimination. 63th World Health Assembly. 2010. Provisional agenda item 11.14. Accessed 726. Carod-Artal FJ, Gascon J. Chagas disease and stroke. Lancet Neurol. 727. Lima-Costa MF, Matos DL, Ribeiro AL. Chagas disease predicts 10-year stroke mortality in community-dwelling elderly: the Bambui Cohort Study of Aging. Stroke. 2010;41:2477 2482. doi: 10.1161/ 728. de Sousa AS, Xavier SS, Rodriguez de Freitas GR, Hasslocher-Moreno A. Prevention strategies of cardioembolic ischemic stroke in Chagas disease. Arq Bras Cardiol. 2008;91:306 310. doi: 10.1590/s0066- 729. Connor MD, Lammie GA, Bell JE, Warlow CP, Simmonds P, Brettle RD. Cerebral infarction in adult AIDS patients: observations from the Edinburgh HIV Autopsy Cohort. Stroke. 2000;31:2117 2126. doi: 730. Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K. Autopsy find- ings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med. 2002;126:182 190. doi: 10.1043/0003- 731. Misra UK, Kalita J, Maurya PK. Stroke in tuberculous meningitis. J Neurol 732. Anderson NE, Somaratne J, Mason DF, Holland D, Thomas MG. Neurological and systemic complications of tuberculous meningitis and its treatment at Auckland City Hospital, New Zealand. J Clin Neurosci. 733. 